We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAdvanced Oncotherapy Share News (AVO)

  • This share is currently suspended. It was suspended at a price of 1.925

Share Price Information for Advanced Oncotherapy (AVO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.925
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.925
AVO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Bankers net assets drop; Invinity Energy wins funds

Wed, 18th Jan 2023 21:58

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

Advanced Oncotherapy PLC - London-based particle therapy for cancer treatment - Estimates a total project cost of GBP75 million to GBP85 million for 2023 and 2024 for its Light system. Says that it completed the construction of the patient treatment room and the physical installation of the Light patient positioning system. Says that active cost reduction initiatives are now underway. Is undertaking key steps to reduce operational spending by over 30% in the next 90 days.

----------

Quantum Exponential Group PLC - quantum technology investment firm - Records a pretax loss of GBP832,291 in the six months to October 31. Revenue amounts to GBP8,030. "Despite the current global economic difficulties, the outlook for Quantum Exponential remains favourable. With increasing support from the UK government for the quantum technology sector, an outstanding advisory board and growing network, the next 12 months should prove to be a very exciting time for Quantum Exponential and its shareholders," Chief Executive Steven Metcalfe comments.

----------

Bankers Investment Trust PLC - aims for capital growth in excess of the FTSE World Index and annual dividend growth ahead of inflation - Records a total net asset value return of 11.3% in the year to October 31, underperforming its benchmark, the FTSE World Index. Net asset value as at October 31 falls to 105.1 pence from 120.9p the year prior. Attributes this to a turbulent market backdrop with surging inflation and a deteriorating economic outlook that has resulted in sharp falls in both bond and equity prices. Declares total dividend of 2.328p, up from 2.176p.

----------

Invinity Energy Systems PLC - London-based utility-grade energy storage manufacturer - Says that it was awarded GBP708,371 of funding from the UK government's Department for Business, Energy & Industrial Strategy under phase 1 of the Longer Duration Energy Storage Demonstration competition. The funds are to carry out a comprehensive planning and feasibility study for a large scale, grid-connected vanadium flow battery project in the UK. "We are very grateful to BEIS for the support we have received to date through our participation in the LODES programme. Technologies such as vanadium flow batteries, engineered and assembled in the UK, are playing an ever-greater role in accelerating progress towards net zero, in no small part thanks to initiatives such as this. With this submission now completed, we believe that Invinity and its partners have made a significant step towards the development and deployment of what could be a highly significant UK energy storage project," Chief Development Officer Jonathan Marren comments.

----------

Savannah Resources PLC - London-based lithium development company - Says that the social impact assessment being undertaken at the Barroso lithium project by the Community Insights Group conducted interviews with local residents during October to ascertain the main issues about the project. "I express my thanks to all community members who agreed to take part in this initial survey conducted by Community Insights, we look forward to hearing and engaging with many more local people as the process continues," CEO Dale Ferguson says.

----------

Shanta Gold Ltd - Guernsey-based east Africa-focused gold producer, developer and explorer - Records an 18% rise in gold production to 65,209 ounces year-on-year. Registers annual throughput of 884,702 tonnes milled, up 6% from 2021. Says that phase 2 drilling in West Kenya continued to deliver encouraging assay results. Guides for annual production for its New Luika gold mine of 66,000 ounces to 72,000 ounces at AISC.

----------

Rambler Metals & Mining PLC - Surrey, England-based copper and gold producer - In the final quarter of 2022, its Ming Mine mine's averaged ore production amounts to 1,045 dry metric tonnes per day, up from 998 dmt per day a quarter prior. Records Nugget Pond copper and gold milling facility throughput of 1,119 dmt per operating day at a feed grade of 1.84% copper, up from 1,177 dmt per operating day at a feed grade of 1.75% copper in the previous quarter.

----------

By Abby Amoakuh, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
2 Apr 2024 17:35

TRADING UPDATES: Sareum ups retail offer; SThree nabs former ITV exec

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
29 Feb 2024 18:52

EARNINGS AND TRADING: Frontier IP sells last of Exscientia holding

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
2 Feb 2024 14:06

IN BRIEF: Advanced Oncotherapy eyes USD15 million tranche in February

Advanced Oncotherapy PLC - London-based provider of proton therapy for cancer treatment - Regarding its recapitalisation plan, company works alongside investor towards initial tranche of funding, which it expects to be about USD15 million to be received this month. However, it adds that there can be no guarantee that this funding will be received, nor that it will be received on time. Further, Advanced Oncotherapy says it remains in advanced talks with a third-party investor regarding a short-term loan facility which would provide the company with additional short term bridge financing.

Read more
9 Jan 2024 14:06

IN BRIEF: Advanced Oncotherapy in advanced talks regarding loan

Advanced Oncotherapy PLC - London-based provider of proton therapy for cancer treatment - Continues to work on its recapitalisation plan with an unnamed third party investor. Says discussions are at an advanced stage but has not entered into any binding agreements with the investor, nor received any funds. This comes after it signed a non-binding term sheet with the investor in October. The investor is expected to provide funding of up to USD80 million to meet the company's cashflow requirements through to the European certification of the LIGHT System. Notes the treatment of first patients with LIGHT is now targeted for 2024 with certification of the LIGHT System to follow thereafter. Anticipates the financing to be a mixture of equity and debt financing. The firm currently owes GBP28 million to trade and other unsecured creditors and GBP41 million of financial debt.

Read more
23 Oct 2023 18:51

IN BRIEF: Advanced Oncotherapy in talks over possible cash injection

Advanced Oncotherapy PLC - London-based provider of proton therapy for cancer treatment - Updates on financing discussions and current financial position. Signs non-binding term sheet with a third-party investor. Investor is expected to provide funding of up to USD80 million to meet the company's cashflow requirements through to the European certification of the LIGHT System. Notes the treatment of first patients with LIGHT is now targeted for 2024 with certification of the LIGHT System to follow thereafter. Anticipates the financing to be a mixture of equity and debt financing.

Read more
3 Oct 2023 18:29

IN BRIEF: Advanced Oncotherapy results delayed, funding talks continue

Advanced Oncotherapy PLC - London-based provider of proton therapy for cancer treatment - On Friday, says it is not in a position to publish its accounts for the year ended December 31, 2022, and the unaudited interim results for the six months ended June 30, together with the 2022 annual report. Explains the 2023 interim results are contingent on the finalisation and publication of the 2022 annual report.

Read more
17 Jul 2023 21:41

Advanced Oncotherapy plans to raise up to GBP110 million

(Alliance News) - Advanced Oncotherapy PLC on Monday announced a prospective recapitalisation and funding plan to raise up to GBP110 million.

Read more
30 Jun 2023 19:54

TRADING UPDATES: Jadestone Energy holds production and capex targets

(Alliance News) - The following is a round-up of updates by London-listed companies, issued Friday and not separately reported by Alliance News:

Read more
2 Jun 2023 19:37

IN BRIEF: Advanced Oncotherapy optimistic of securing further funding

Advanced Oncotherapy PLC - London-based particle therapy for cancer treatment company - Announces it has received a conversion notice for a portion of the convertible notes, which were issued to a French counterparty, as announced March 1 into new shares in the company. Says 10 convertible notes have been converted worth GBP50,000 at a conversion price of GBP0.25. Company also pays GBP56,702 conversion fee as the conversion price is below the nominal value of the shares. States this will be settled through the issuance of 756,020 new shares. Further, says in talks to raise further funding under the secured loan note agreement as well as through other non-dilutive financing options and is hopeful of securing additional financing during June 2023. Optimistic of a satisfactory outcome on the financing options being explored. In addition, company says it has issued convertible notes totalling GBP34,600 under its secured convertible loan note agreement.

Read more
15 May 2023 21:10

TRADING UPDATES: Online Blockchain keeping ADVFN at "arms length"

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
18 Apr 2023 10:38

Advanced Oncotherapy considers US sale of business to secure funding

(Alliance News) - Advanced Oncotherapy PLC on Tuesday said it is continuing to consider funding options to allow it to complete its first Light machine and begin treating patients later this year.

Read more
20 Mar 2023 13:06

IN BRIEF: Advanced Oncotherapy receives GBP1.2 million in funds

Advanced Oncotherapy PLC - London-based particle therapy for cancer treatment - Receives balance of funds, about GBP1.2 million, due under the secured convertible loan agreements entered into by the company with investors and directors. The balance of funds that have been received by the company includes GBP500,000 that was due to be received from Executive Chair Michael Sinclair by mid-March 2023. Currently, GBP5.0 million has been received from investors under the secured convertible loan note. Says it is also taking steps to raise additional financing.

Read more
1 Mar 2023 21:15

TRADING UPDATES: Galantas to raise GBP1.2 million in private placement

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
30 Dec 2022 14:33

IN BRIEF: Advanced Oncotherapy non-exec director buys 500,000 shares

Advanced Oncotherapy PLC - London-based particle therapy for cancer treatment - Non-Executive Director Michael Bradfield buys 500,000 shares at 13.17 pence, worth GBP65,825, on Thursday. Now has 8.4 million shares, a 1.6% stake.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.